Registration is now open for the inaugural Optical Dispensers Australia industry conference, which takes place in Sydney from Friday 28 – Saturday 29 April

Phase 2b study results of OPT-302, an anti-VEGF-C/-D ‘trap’ agent administered in combination with Lucentis (ranibizumab) for the treatment of wet age-related macular degeneration

Eye care professionals have been asked to assist Guide Dogs Australia by suggesting their patients with low vision or blindness participate in a survey.

Myopia Profile has launched Myopia Management with Spectacles, an online course designed to support and accelerate this form of treatment adoption and clinical success.